Clinical Trials Browser

Phase EARLY_PHASE1 × eribulin × CNS × Clear all

NCT02338037 2024-03-19

Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

Phase EARLY_PHASE1 Completed

Brain Neoplasms